The expression of HMGB1 was increased in labial glandular tissue and serum of SS patients. Serum HMGB1 levels were higher in SSA positive or extra-glandular involvement. Treatment with anti-HMGB1 antibodies improved xerostomia and xerophthalmia in mouse models. This evidence concerns the gene HMGB1 and synovial sarcoma.